Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Amwell to report third quarter 2024 operating results
-
CA Indosuez Expands Investment Options by Connecting to ARTEX Global Markets
-
Gilat Secures Approximately $15 Million in Orders from Leading Satellite Operators for GEO, MEO and LEO Constellations
-
Massachusetts Schools Gain Free Access to STEM Career Exploration Tools
-
Wisconsin Schools Gain Free Access to STEM Career Exploration Tools
-
Illinois Schools Gain Free Access to STEM Career Exploration Tools
-
Shaq-a-Roni Returns to Papa Johns, Reinforcing Its Commitment to Better
-
Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor
-
Premier American Uranium Completes Successful Inaugural Drill Program at the Cyclone ISR Uranium Project, Great Divide Basin, Wyoming
-
Pre-Feasibility Study – Kharmagtai Copper-Gold Project
-
Advent Technologies Reports Q1 2024 Results
-
BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder
-
Steakholder Foods® Shares Letter from the CEO, Arik Kaufman
-
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting
-
Mobilicom Showcases its Military Grade Field-Proven Drone Solutions at the Association of the U.S. Army (AUSA) 2024 Annual Meeting & Exposition in Washington D.C.
-
Advent Technologies Reports Q2 2024 Results
-
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
-
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
-
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
-
Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance
-
Xtract One Announces Fiscal 2024 Fourth Quarter Conference Call
-
Er-Kim CEO Cem Zorlular Recognized as a Patient Champion on the 2024 PharmaVoice 100
-
TransPerfect’s GlobalLink Named Leading Localization Platform in G2 Fall 2024 Report
-
Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis
-
Mobilicom Showcases its Military Grade Field-Proven Drone Solutions at the Association of the U.S. Army (AUSA) 2024 Annual Meeting & Exposition in Washington D.C.
-
Steakholder Foods® Shares Letter from the CEO, Arik Kaufman
-
MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
-
Beamr and Bridge Digital Inc. to Deliver “Forever Video” to Broadcasters and Video Streamers
-
Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024
-
Coteau Grove Project Celebrates Two-Year Anniversary of Playing Shows for a Good Cause
-
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
-
Gray Media to Debut New National Anthem Rendition Across All Stations
-
High Efficiency Electrolyser Cells Complete Key Durability Test
-
Fossil Group, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
-
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
-
OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX
-
BiomX Announces a Mandatory Unit Separation
-
CECO Environmental to Release Third Quarter Earnings and Host Conference Call on October 29
-
Bank of Åland Plc to decrease prime rate
-
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
-
CMR Surgical receives U.S. FDA Marketing Authorization for next-generation Versius Surgical System
-
Pharvaris to Host Virtual Investor Event on October 23, 2024
-
DT Midstream to Announce Third Quarter 2024 Financial Results, Schedules Earnings Call
-
Nordic American Tankers Ltd (NYSE: NAT) – Long term contract with a major energy company
-
Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAR
-
AI knowledge thought leaders and practitioners to convene at eGain Solve 2024
-
Planet 13 Strengthens Florida Retail Footprint with Opening of 28th Dispensary Located in Port Orange near Daytona Beach
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024
-
Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
